Hays Advisory Lowers stake in USANA Health Sciences (USNA)

USANA Health Sciences (USNA) : Hays Advisory reduced its stake in USANA Health Sciences by 9.64% during the most recent quarter end. The investment management company now holds a total of 51,222 shares of USANA Health Sciences which is valued at $7,593,662 after selling 5,467 shares in USANA Health Sciences , the firm said in a disclosure report filed with the SEC on Oct 11, 2016.USANA Health Sciences makes up approximately 1.29% of Hays Advisory’s portfolio.

Other Hedge Funds, Including , Bnp Paribas Arbitrage Sa boosted its stake in USNA in the latest quarter, The investment management firm added 210 additional shares and now holds a total of 679 shares of USANA Health Sciences which is valued at $97,586.Independent Portfolio Consultants reduced its stake in USNA by selling 15 shares or 6.38% in the most recent quarter. The Hedge Fund company now holds 220 shares of USNA which is valued at $31,618. USANA Health Sciences makes up approx 0.01% of Independent Portfolio Consultants’s portfolio.

USANA Health Sciences closed down -1.85 points or -1.25% at $146.4 with 1,35,723 shares getting traded on Tuesday. Post opening the session at $148.2, the shares hit an intraday low of $145.2259 and an intraday high of $150 and the price fluctuated in this range throughout the day.Shares ended Tuesday session in Red.

On the company’s financial health, USANA Health Sciences reported $1.77 EPS for the quarter, missing the analyst consensus estimate by $ -0.04 based on the information available during the earnings call on May 3, 2016. Analyst had a consensus of $1.81. The company had revenue of $240.45 million for the quarter, compared to analysts expectations of $244.05 million. The company’s revenue was up 9.6% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.50 EPS.

Many Wall Street Analysts have commented on USANA Health Sciences. Company shares were Reiterated by DA Davidson on Jul 28, 2016 to “Neutral”, Firm has raised the Price Target to $ 150 from a previous price target of $135 .

USANA Health Sciences Inc. develops and manufactures science-based nutritional and personal care products. The Company has operations in approximately 19 markets across the world where it distributes and sells its products by way of direct selling. The Company operates as a direct selling company and reports revenue in two geographic regions: Americas and Europe and Asia Pacific which includes three sub-regions as: Southeast Asia Pacific Greater China and North Asia. Americas and Europe includes the United States Canada Mexico Colombia the United Kingdom France Belgium and the Netherlands. Southeast Asia Pacific includes Australia New Zealand Singapore Malaysia the Philippines and Thailand; Greater China includes Hong Kong Taiwan and China and North Asia includes Japan and South Korea.

Comments (0)

Leave a Reply

Your email address will not be published. Required fields are marked *

USANA Health Sciences - Is it time to Sell?

Top Brokerage Firms are advising their investors on USANA Health Sciences. Subscribe to MoneyFlowIndex.Org Pre-Market Alerts, You will be the first to know the street buzz.